132 related articles for article (PubMed ID: 20633117)
41. Antidepressant-like activity of Glycyrrhiza glabra L. in mouse models of immobility tests.
Dhingra D; Sharma A
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):449-54. PubMed ID: 16443316
[TBL] [Abstract][Full Text] [Related]
42. Antidepressant-like properties of some serotonin receptor ligands and calcium channel antagonists measured with the forced swimming test in mice.
Biała G
Pol J Pharmacol; 1998; 50(2):117-24. PubMed ID: 9798263
[TBL] [Abstract][Full Text] [Related]
43. New ligands at the melatonin binding site MT(3).
Boussard MF; Truche S; Rousseau-Rojas A; Briss S; Descamps S; Droual M; Wierzbicki M; Ferry G; Audinot V; Delagrange P; Boutin JA
Eur J Med Chem; 2006 Mar; 41(3):306-20. PubMed ID: 16414149
[TBL] [Abstract][Full Text] [Related]
44. Interaction of zinc with antidepressants in the tail suspension test.
Cunha MP; Machado DG; Bettio LE; Capra JC; Rodrigues AL
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1913-20. PubMed ID: 18824054
[TBL] [Abstract][Full Text] [Related]
45. Antidepressant-like effect of leptin in streptozotocin-induced diabetic mice.
Hirano S; Miyata S; Kamei J
Pharmacol Biochem Behav; 2007 Jan; 86(1):27-31. PubMed ID: 17258301
[TBL] [Abstract][Full Text] [Related]
46. Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice.
Nielsen DM; Carey GJ; Gold LH
Eur J Pharmacol; 2004 Sep; 499(1-2):135-46. PubMed ID: 15363960
[TBL] [Abstract][Full Text] [Related]
47. Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice.
Peng WH; Lo KL; Lee YH; Hung TH; Lin YC
Life Sci; 2007 Aug; 81(11):933-8. PubMed ID: 17804020
[TBL] [Abstract][Full Text] [Related]
48. Antidepressant-like effect of the extract from leaves of Schinus molle L. in mice: evidence for the involvement of the monoaminergic system.
Machado DG; Kaster MP; Binfaré RW; Dias M; Santos AR; Pizzolatti MG; Brighente IM; Rodrigues AL
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):421-8. PubMed ID: 17182164
[TBL] [Abstract][Full Text] [Related]
49. The antidepressant activity of Hypericum perforatum L. measured by two experimental methods on mice.
Bach-Rojecky L; Kalodjera Z; Samarzija I
Acta Pharm; 2004 Jun; 54(2):157-62. PubMed ID: 15274759
[TBL] [Abstract][Full Text] [Related]
50. Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test.
Galeotti N; Bartolini A; Ghelardini C
Neuropharmacology; 2006 Mar; 50(3):309-16. PubMed ID: 16249008
[TBL] [Abstract][Full Text] [Related]
51. Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression.
Ago Y; Arikawa S; Yata M; Yano K; Abe M; Takuma K; Matsuda T
Neuropharmacology; 2008 Dec; 55(8):1355-63. PubMed ID: 18796307
[TBL] [Abstract][Full Text] [Related]
52. A proposal of decision tree to screen putative antidepressants using forced swim and tail suspension tests.
Bourin M; Chenu F; Ripoll N; David DJ
Behav Brain Res; 2005 Nov; 164(2):266-9. PubMed ID: 16087251
[TBL] [Abstract][Full Text] [Related]
53. Antidepressant-like effects of endogenous histamine and of two histamine H1 receptor agonists in the mouse forced swim test.
Lamberti C; Ipponi A; Bartolini A; Schunack W; Malmberg-Aiello P
Br J Pharmacol; 1998 Apr; 123(7):1331-6. PubMed ID: 9579727
[TBL] [Abstract][Full Text] [Related]
54. The melatonin analog 5-MCA-NAT increases endogenous dopamine levels by binding NRH:quinone reductase enzyme in the developing chick retina.
Sampaio Lde F; Mesquita FP; de Sousa PR; Silva JL; Alves CN
Int J Dev Neurosci; 2014 Nov; 38():119-26. PubMed ID: 25218627
[TBL] [Abstract][Full Text] [Related]
55. Melatonin inhibits granulocyte adhesion to ICAM via MT3/QR2 and MT2 receptors.
Černyšiov V; Mauricas M; Girkontaite I
Int Immunol; 2015 Dec; 27(12):599-608. PubMed ID: 26031343
[TBL] [Abstract][Full Text] [Related]
56. Quinone reductase 2 as a promising target of melatonin therapeutic actions.
Boutin JA
Expert Opin Ther Targets; 2016; 20(3):303-17. PubMed ID: 26465080
[TBL] [Abstract][Full Text] [Related]
57. Measuring Binding at the Putative Melatonin Receptor MT3.
Legros C; Dupuis P; Ferry G; Boutin JA
Methods Mol Biol; 2022; 2550():283-289. PubMed ID: 36180699
[TBL] [Abstract][Full Text] [Related]
58. Antidepressant-like activity of the melatonin receptor antagonist, luzindole (N-0774), in the mouse behavioral despair test.
Dubocovich ML; Mogilnicka E; Areso PM
Eur J Pharmacol; 1990 Jul; 182(2):313-25. PubMed ID: 2168835
[TBL] [Abstract][Full Text] [Related]
59. Insights into the redox cycle of human quinone reductase 2.
Reybier K; Perio P; Ferry G; Bouajila J; Delagrange P; Boutin JA; Nepveu F
Free Radic Res; 2011 Oct; 45(10):1184-95. PubMed ID: 21762045
[TBL] [Abstract][Full Text] [Related]
60. Effect of Melatonin and Its Analogs on Tear Secretion.
Navarro Gil FJ; Huete-Toral F; Crooke A; Dominguez Godinez CO; Carracedo G; Pintor J
J Pharmacol Exp Ther; 2019 Oct; 371(1):186-190. PubMed ID: 31371479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
